Skip to main content

LV Fibroma vs Rhabdomyoma

Echo-focused differentiating points πŸ‘‰:



Rhabdomyoma: Usually multiple, homogeneous echogenic masses, intramyocardial, no calcification, often in infants, tendency to regress.


Fibroma: Typically solitary, very bright echogenic mass with shadowing due to calcification, well-circumscribed, often larger, does not regress, commonly in LV free wall or septum.

To confirm LV fibroma vs rhabdomyoma, the key modality is Cardiac MRI — echo alone cannot definitively distinguish them. Here’s the clean, practical approach used clinically:



---


✅ How to Confirm LV Fibroma vs Rhabdomyoma


1. Cardiac MRI (Gold Standard)


Rhabdomyoma


T1: Iso / mildly hyperintense


T2: Hyperintense


LGE: No or minimal enhancement


Often multiple lesions



Fibroma


T1: Hypointense


T2: Hypointense


LGE: Intense, central enhancement (classic “bright core”)


Well-defined, usually solitary



→ Pattern of LGE is the single best differentiator.



---


2. Clinical Clues


Rhabdomyoma


Infant with multiple masses


Features of Tuberous sclerosis


Tumor shrinking on follow-up scan



Fibroma


Older child


Solitary, large LV wall mass


Ventricular arrhythmias (common)




---


3. Follow-up Imaging


Rhabdomyoma decreases over months


Fibroma stays same or increases → confirms fibrotic tumor




---


4. Genetic / Syndromic Workup


If rhabdomyoma suspected → Tuberous sclerosis evaluation (TSC1/TSC2)


Fibroma has no strong genetic link




---


5. Histology (rarely needed)


Only if diagnosis unclear or mass causing severe symptoms


Surgery + biopsy mainly for fibroma




---


⭐ Practical Rule


If MRI shows strong central LGE → fibroma.

If MRI shows no LGE and multiple lesions → rhabdomyoma.


Comments

Popular posts from this blog

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...